Join STAT’s senior science writer, Sharon Begley, for an online chat about the latest developments with the genome-editing technology CRISPR. She’ll take your questions about two new studies raising concerns about whether CRISPR’d cells might become cancerous, about the CRISPR patent wars, and about the ongoing science summarized in STAT’s CRISPR Trackr.
Read the chat archive below
About the Author Reprints
